Get the full picture
Sign in to uncover key details.
Evozyne
Business Services · Illinois, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2430 N Halsted St, Chicago, Illinois, 60...Phone Number
(872) 757-4050Website
www.evozyne.comRevenue
$14.2 MillionIndustry
About Evozyne
Evozyne specializes in designing novel therapeutic proteins using generative AI to address the challenges of immune-mediated diseases. Their AI-native platform, EvoGen, optimizes protein sequences for enhanced potency, stability, specificity, and immunogenicity. The company operates EvoLab, a high-throughput facility that synthesizes and tests thousands of protein candidates, generating proprietary data for their immunology pipeline. Evozyne aims to create scalable immune therapies that can effectively treat patients who do not respond to existing therapies.Explore more
Evozyne Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Evozyne
Compare insights from companies similar to Evozyne, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Evozyne Tech Stack
A closer look at the technologies used by Evozyne
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Evozyne
Sign Up For FreeTo access detailed company insights
Evozyne specializes in designing novel therapeutic proteins using generative AI to address the challenges of immune-mediated diseases. Their AI-native platform, EvoGen, optimizes protein sequences for enhanced potency, stability, specificity, and immunogenicity. The company operates EvoLab, a high-throughput facility that synthesizes and tests thou... Read More
